Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Covid-19 manufacturing roundup: Biden doubles down on vaccination plan with 100M-dose order; BioNTech, Pfizer ready to increase manufacturing; J&J experiences delivery woes

5 years ago

Covid-19 roundup: Pfizer/BioNTech release real-world evidence of vaccine efficacy; EMA gives J&J shot thumbs up

5 years ago

GlaxoSmithKline, Vir gear up for EUA, citing early PhIII Covid-19 win with 'best-in-class' antibody contender

5 years ago

In the latest twist to IL-6 roller coaster, Roche's Actemra fails PhIII Covid-19 Veklury combo trial

5 years ago

Janet Woodcock and Francis Collins dish on lessons learned from the pandemic

5 years ago

Covid-19 roundup: US lands another 100M-dose contract from J&J to back Biden's pledge; Pfizer and BioNTech could produce 3B vaccine doses next year

5 years ago

Eli Lilly tops up positive PhIII data for its Covid-19 antibody combo at ‘the optimal dose’

5 years ago

Covid-19 roundup: Abivax pulls the plug on its anti-inflammatory treatment; J&J says it could fall short on Q2 vaccine supply for EU — report

5 years ago

Covid-19 roundup: Merck and Ridgeback report early data for an oral antiviral to fight the pandemic; Austria pulls a batch of AstraZeneca’s vaccine after patient death

5 years ago

Covid-19 roundup: RECOVERY trial halts recruitment for colchicine study after finding ‘no convincing evidence’; Italy blocks AstraZeneca vaccine shipment meant for Australia

5 years ago

Brii Bio joins the NIH graveyard alongside GSK, Lilly after flopping antibody study in hospitalized Covid-19 patients

5 years ago

Apellis joins the growing number of biopharmas scrapping a failed Covid-19 program after an early flop

5 years ago

Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU

5 years ago

Covid-19 roundup: EMA starts rolling review of Russia's Sputnik V; Novavax says shot is 51% effective against variant in South Africa

5 years ago

GSK, Vir's hopes for a Covid-19 antibody fall flat in NIH 'master protocol' with no benefit in hospitalized patients

5 years ago

Covid-19 roundup: Merck prepares new study on their $425M Covid drug; COVAX begins rollout but huge disparities still loom

5 years ago

After bailing on Covid-19 vaccines, Merck will team up with J&J to produce its shot as part of unusual Big Pharma pact

5 years ago

Covid-19 roundup: AstraZeneca ships first COVAX doses as Canada recommends against 65+ use; Inovio, still stuck in PhIII, to respond to FDA in May

5 years ago

Feds clear the road for J&J to start delivering millions of doses of their Covid-19 vaccine — but frets linger about runner-up status

5 years ago

J&J adcomm live blog: Committee votes 22-0 to recommend an FDA OK for the J&J vaccine, setting up 3rd US Covid-19 jab

5 years ago

Covid-19 roundup: US secures 100,000 doses of Eli Lilly's antibody cocktail; Merck's $356M supply deal on hold as FDA asks for more data

5 years ago

Regeneron halts placebo enrollment in Covid-19 cocktail trial after IDMC finds 'clear' efficacy — but there are no data yet

5 years ago

Covid-19 roundup: Pfizer/BioNTech shot just as effective in real world, study says, as pair preps variant booster shots

5 years ago

GlaxoSmithKline rethinks strategy for Covid-19 antibody — not the Vir ones — after trial flop. Is there hope in high-risk patients?

5 years ago

First page Previous page 32 33 343536 37 38 Next page Last page